Search

Search Results

• CO:01:1 | Efficacy and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study of 115 patients Marco Lanzillotta¹, Jens Vikse², Elisabetta Goni³, Veronica Batani¹, Jasmin Mahajne¹, Lorenzo Dagna¹, Emanuel Della Torre¹. | ¹Unit of Immunology, Rheumatology, Allergy, and Rare Disease, IRCCS Ospedale San Raffaele, Milano, Italy; ²Department of Rheumatology, Stavanger University Hospital, Norway; ³Department of Medicine II, University Hospital, Ludwig Maximilian University, Munich, Germany

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1961

  438
• 

  IgG4-related disease: findings from a retrospective cohort in Colombia

  Diana N. Rincón-Riaño, Daniel E. Rodríguez-Ariza, Cristhyan Pacheco, Laura J. Garcia-Ballesteros, Luisa Fernanda Galindo, Fabio A. Torres

  03-11-2025

  https://doi.org/10.4081/reumatismo.2025.1887

  1175

  Downloads: 352